The closing price of Atyr Pharma Inc (NASDAQ: LIFE) was $2.00 for the day, up 4.44% from the previous closing price of $1.91. In other words, the price has increased by $+0.0850 from its previous closing price. On the day, 1200701 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
Our analysis of LIFE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.27 and its Current Ratio is at 6.27. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.15.
On October 12, 2021, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $22.
On September 21, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $19.Piper Sandler initiated its Overweight rating on September 21, 2021, with a $19 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 06 ’24 when Broadfoot Jill Marie sold 1,590 shares for $1.69 per share. The transaction valued at 2,687 led to the insider holds 20,821 shares of the business.
Shukla Sanjay bought 12,000 shares of LIFE for $14,136 on Dec 12 ’23. The President and CEO now owns 106,173 shares after completing the transaction at $1.18 per share. On Dec 11 ’23, another insider, Shukla Sanjay, who serves as the President and CEO of the company, bought 3,000 shares for $1.17 each. As a result, the insider paid 3,510 and bolstered with 94,173 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LIFE now has a Market Capitalization of 135.50M and an Enterprise Value of 52.43M. For the stock, the TTM Price-to-Sale (P/S) ratio is 387.14 while its Price-to-Book (P/B) ratio in mrq is 1.40. Its current Enterprise Value per Revenue stands at 148.52 whereas that against EBITDA is -1.00.
Stock Price History:
Over the past 52 weeks, LIFE has reached a high of $2.70, while it has fallen to a 52-week low of $1.08. The 50-Day Moving Average of the stock is 1.7797, while the 200-Day Moving Average is calculated to be 1.6642.
Shares Statistics:
LIFE traded an average of 528.14K shares per day over the past three months and 716.42k shares per day over the past ten days. A total of 67.75M shares are outstanding, with a floating share count of 65.34M. Insiders hold about 3.56% of the company’s shares, while institutions hold 60.45% stake in the company. Shares short for LIFE as of Feb 29, 2024 were 108.23k with a Short Ratio of 0.55, compared to 99.41k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.18% and a Short% of Float of 0.27%.
Earnings Estimates
The firm’s stock currently is rated by 5 analysts. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.29, while EPS last year was -$0.29. The consensus estimate for the next quarter is -$0.24, with high estimates of -$0.19 and low estimates of -$0.3.
Analysts are recommending an EPS of between -$0.75 and -$1.19 for the fiscal current year, implying an average EPS of -$0.94. EPS for the following year is -$0.95, with 4 analysts recommending between -$0.64 and -$1.11.
